Group Photo (IMAGE)

The University of Hong Kong

Group Photo

Caption

Professor Ruby Hoo Lai-chong (first, right), Department of Pharmacology and Pharmacy of HKUMed, and her research team have successfully developed a neutralising monoclonal antibody, 6H2, which targets a harmful protein A-FABP known to exacerbate damage caused by ischaemic stroke. The findings will offer potential for a highly effective pharmacological therapy for patients with ischemia stroke.

Credit

The University of Hong Kong

Usage Restrictions

N/A

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.